Dorsomorphin inhibits AMPK, upregulates Wnt and Foxo genes and promotes the activation of dormant follicles

Julie Feld Madsen,Emil Hagen Ernst,Mahboobeh Amoushahi,Margit Dueholm,Erik Ernst,Karin Lykke-Hartmann
DOI: https://doi.org/10.1038/s42003-024-06418-9
IF: 6.548
2024-06-21
Communications Biology
Abstract:AMPK is a well-known energy sensor regulating cellular metabolism. Metabolic disorders such as obesity and diabetes are considered detrimental factors that reduce fecundity. Here, we show that pharmacologically induced in vitro activation (by metformin) or inhibition (by dorsomorphin) of the AMPK pathway inhibits or promotes activation of ovarian primordial follicles in cultured murine ovaries and human ovarian cortical chips. In mice, activation of primordial follicles in dorsomorphin in vitro-treated ovaries reduces AMPK activation and upregulates Wnt and FOXO genes, which, interestingly, is associated with decreased phosphorylation of β-catenin. The dorsomorphin-treated ovaries remain of high quality, with no detectable difference in reactive oxygen species production, apoptosis or mitochondrial cytochrome c oxidase activity, suggesting safe activation. Subsequent maturation of in vitro-treated follicles, using a 3D alginate cell culture system, results in mature metaphase eggs with protruding polar bodies. These findings demonstrate that the AMPK pathway can safely regulate primordial follicles by modulating Wnt and FOXO genes, and reduce β-catenin phosphorylation.
biology
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to explore the role of the AMPK (Adenosine Monophosphate-Activated Protein Kinase) pathway in follicle activation and to promote the activation of dormant primordial follicles through pharmacological regulation of AMPK. Specifically, the paper attempts to address the following key issues: 1. **The Role of AMPK in Follicle Activation**: - Investigate the effects of inhibiting AMPK (using dorsomorphin) or activating AMPK (using metformin) on the activation of dormant follicles in mouse and human ovaries. 2. **Expression Changes of Wnt and Foxo Genes**: - Explore the upregulation of Wnt and Foxo genes following AMPK inhibition and analyze how these gene changes affect follicle activation and development. 3. **Reduction in β-catenin Phosphorylation**: - Study the reduction in β-catenin phosphorylation after AMPK inhibition and verify its relationship with the Wnt/β-catenin signaling pathway. 4. **Safety of Oocyte Quality**: - Examine whether the quality of oocytes is affected after dorsomorphin treatment, including changes in apoptosis, reactive oxygen species (ROS) generation, and mitochondrial cytochrome c oxidase activity. Through these studies, the paper seeks to reveal the specific mechanisms of the AMPK pathway in follicle activation and explore its potential as a new approach for treating infertility.